BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

43 related articles for article (PubMed ID: 35727472)

  • 1. Clinically translatable gold nanozymes with broad spectrum antioxidant and anti-inflammatory activity for alleviating acute kidney injury.
    Zhang DY; Tu T; Younis MR; Zhu KS; Liu H; Lei S; Qu J; Lin J; Huang P
    Theranostics; 2021; 11(20):9904-9917. PubMed ID: 34815794
    [No Abstract]   [Full Text] [Related]  

  • 2. Indole-3-carboxaldehyde alleviates cisplatin-induced acute kidney injury in mice by improving mitochondrial dysfunction via PKA activation.
    Yuan P; Feng A; Wei Y; Li S; Fu Y; Wang X; Guo M; Feng W; Zheng X
    Food Chem Toxicol; 2024 Apr; 186():114546. PubMed ID: 38408633
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual-targeted nanoparticles with removing ROS inside and outside mitochondria for acute kidney injury treatment.
    Zhao M; Guo J; Tian C; Yan M; Zhou Y; Liu C; Pang M; Du B; Cheng G
    Nanomedicine; 2024 Jan; 55():102725. PubMed ID: 38007068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of proteins related to SIS3 by iTRAQ and PRM-based comparative proteomic analysis in cisplatin-induced acute kidney injury.
    Huang J; Ye J; Gao Y; Wang Y; Zhao Q; Lou T; Lai W
    PeerJ; 2024; 12():e17485. PubMed ID: 38854800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH-Activatable Pre-Nanozyme Mediated H
    Jiang W; Hou X; Qi Y; Wang Z; Liu Y; Gao XJ; Wu T; Guo J; Fan K; Shang W
    Adv Sci (Weinh); 2024 May; 11(18):e2303901. PubMed ID: 38445847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The underlying mechanisms of cisplatin-induced nephrotoxicity and its therapeutic intervention using natural compounds.
    Zhang D; Luo G; Jin K; Bao X; Huang L; Ke J
    Naunyn Schmiedebergs Arch Pharmacol; 2023 Nov; 396(11):2925-2941. PubMed ID: 37289283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent Advances in Nanomaterials for the Treatment of Acute Kidney Injury.
    Ba X; Ye T; Shang H; Tong Y; Huang Q; He Y; Wu J; Deng W; Zhong Z; Yang X; Wang K; Xie Y; Zhang Y; Guo X; Tang K
    ACS Appl Mater Interfaces; 2024 Mar; 16(10):12117-12148. PubMed ID: 38421602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodegradable Osmium Nanoantidotes for Photothermal-/Chemo- Combined Treatment and to Prevent Chemotherapy-Induced Acute Kidney Injury.
    Long Q; Liao F; Yi H; Wang M; Zhuang J; Zheng Y; Guo W; Zhang DY
    Adv Healthc Mater; 2024 Mar; 13(7):e2302729. PubMed ID: 38097368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Melanin-Based Natural Antioxidant Defense Nanosystem for Theranostic Application in Acute Kidney Injury.
    Sun T; Jiang D; Rosenkrans ZT; Ehlerding EB; Ni D; Qi C; Kutyreff CJ; Barnhart TE; Engle JW; Huang P; Cai W
    Adv Funct Mater; 2019 Nov; 29(48):. PubMed ID: 32055240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vivo and in Vitro Regulatory Effect of Silibinin on Some Metabolic Enzyme Activities against Cobalt Induced Toxicity in Rats: A Biochemical Approach.
    Temel Y; Akkoyun HT; Akkoyun MB; Karagözoğlu F; Melek Ş; Bengü AŞÜ; Erdem SA; Çİftcí M
    ACS Omega; 2023 Dec; 8(48):46144-46150. PubMed ID: 38075778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cisplatin-Induced Kidney Toxicity: Potential Roles of Major NAD
    Iskander A; Yan LJ
    Biomolecules; 2022 Aug; 12(8):. PubMed ID: 36008971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renoprotective mechanisms of Astragaloside IV in cisplatin-induced acute kidney injury.
    Yan W; Xu Y; Yuan Y; Tian L; Wang Q; Xie Y; Shao X; Zhang M; Ni Z; Mou S
    Free Radic Res; 2017; 51(7-8):669-683. PubMed ID: 28750561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NADPH oxidase 4 promotes cisplatin-induced acute kidney injury via ROS-mediated programmed cell death and inflammation.
    Meng XM; Ren GL; Gao L; Yang Q; Li HD; Wu WF; Huang C; Zhang L; Lv XW; Li J
    Lab Invest; 2018 Jan; 98(1):63-78. PubMed ID: 29106395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cisplatin Nephrotoxicity: Novel Insights Into Mechanisms and Preventative Strategies.
    Motwani SS; Kaur SS; Kitchlu A
    Semin Nephrol; 2022 Nov; 42(6):151341. PubMed ID: 37182407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective Effect of Natural Antioxidants on Reducing Cisplatin-Induced Nephrotoxicity.
    Zhou J; Nie RC; Yin YX; Cai XX; Xie D; Cai MY
    Dis Markers; 2022; 2022():1612348. PubMed ID: 36419843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silibinin ameliorates cisplatin-induced acute kidney injury via activating Nfe2l1-mediated antioxidative response to suppress the ROS/MAPK signaling pathway.
    Yang F; Jia M; Deng C; Xiao B; Dai R; Xiang Y
    J Mol Histol; 2022 Aug; 53(4):729-740. PubMed ID: 35727472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-140-5p attenuated oxidative stress in Cisplatin induced acute kidney injury by activating Nrf2/ARE pathway through a Keap1-independent mechanism.
    Liao W; Fu Z; Zou Y; Wen D; Ma H; Zhou F; Chen Y; Zhang M; Zhang W
    Exp Cell Res; 2017 Nov; 360(2):292-302. PubMed ID: 28928081
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.